Home › Studies › PRJNA1142892
PRJNA1142892 SRP523574

Microbiome, cognitive impairment, cancer survivors, Tampa FL

Microbiome modulators in the prevention and mitigation of accelerated aging biology caused by cancer treatment

Case-control study of 148 stool samples from older adults (≥60 years, including cancer survivors and controls) in Tampa, Florida, examining gut microbiome signatures linked to cognitive impairment and cancer survivorship. machine-written summary

148 samples · 148 runs · US · Age unknown · 2025 · 1.53 Gbp / sample

Sources
✓Sequence archive 1,184○Abstract / description✓Full text 148○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,184 sample values (collection date, country, health condition, health condition detail, latitude, location locality, location region, longitude)
○ Abstract / descriptionread; no usable statement
✓ Full text148 sample values (antibiotic exposure) · PMC13575041
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
elderly148
Condition
healthy_control63
other_cancer49
neurological_psychiatric36
Country
US148
Body site
primary148
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 15 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 24 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 96 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 13 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 1.53 Gbp per sample0130Gbp
Community composition
Blautia_A 11.4%Bacteroides 4.5%Ruminococcoides 4.3%Faecalibacterium 4.0%Collinsella 3.9%Roseburia 3.7%Anaerostipes 2.7%Bifidobacterium 2.6%Mediterraneibacter 2.2%Phocaeicola 2.2%Gemmiger 2.1%Fusicatenibacter 2.0%not assigned to a genus 10.2%other genera 44.1%

Genera, mean relative abundance over 98 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category148 100%
country148 100%148
health_condition148 100%148
subject_id0 0%
antibiotic_exposure148 100%148
collection_date148 100%148
detailed_location148 100%
health_condition_detail148 100%148
latitude148 100%148
location_locality148 100%148
location_region148 100%148
longitude148 100%148
Papers (1)
  • Gut microbiome signatures predict cognitive impairment in older cancer survivors. 2026 PMID 41175312 PMC13575041 own_data
Details
Archive description

Cancer patients are living longer thanks to developments in oncology research. Nevertheless, debilitating side effects from cancer treatments such as chemotherapy include increased risk of chronic diseases and multi-organ dysfunction, which mimic accelerated aging. Dysbiosis, or abnormalities in the composition of the gut microbiome, increases inflammation and leads to accelerated aging-related cognitive impairment and a lower quality of life, all of which are made worse by cancer treatments. To learn more about the microbiome profile, shotgun sequencing was applied to stool samples from cancer survivors who were cognitively impaired.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by opus_adjudicated with confidence 0.80. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • host study.description · “cancer survivors who were cognitively impaired”
  • body site study.description · “stool samples from cancer survivors”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN42963622antibiotic_exposurenoR30.70paper.fulltext.methodsuse of antibiotics within the last 30 days
SAMN42963622collection_date2022-03-01R10.90biosample.attribute:collection_date2022-03-01
SAMN42963622countryUSR10.85biosample.attribute:geographical_locationUSA: Florida, Tampa
SAMN42963622health_conditionhealthy_controlR10.70sample.name_rule:aliasNC-HC_1
SAMN42963622health_condition_detailNC-HCR10.70sample.name_rule:aliasNC-HC_1
SAMN42963622latitude27.9517R10.90biosample.attribute:latitude_and_longitude27.9517 N 82.4588 W
SAMN42963622location_localityTampaR10.85biosample.attribute:geographical_locationUSA: Florida, Tampa
SAMN42963622location_regionFloridaR10.85biosample.attribute:geographical_locationUSA: Florida, Tampa
SAMN42963622longitude-82.4588R10.90biosample.attribute:latitude_and_longitude27.9517 N 82.4588 W
Sequencing

148 runs over 148 samples · mean 1.59 Gbp per run (median 1.53 Gbp, total 235.19 Gbp; 148 runs with a base count) · layout PAIRED 148 · platform ILLUMINA 148 · models NextSeq 1000 (148) · 66% of runs with a Sandpiper profile · first public 2025-02-02

Authors (20)

Miller BC first · Haggler JA · Chaudhari DS · Shukla R · Kumar V · Mishra SP · Masternak MM · Holland P · Labyak C · Golden A · Dangiolo M · Arikawa AY · Kociolek J · Fraser A · Williams C · Agronin M · Aymat M · Pledger W · Yadav H · Jain S last

Downloads

PRJNA1142892.csv.gz (4.6 KB) · parquet (76.6 KB) — all 148 samples, every field with route and confidence · PRJNA1142892_determinations.csv.gz (10.2 KB) — 1,332 evidence rows

Samples (148 · every field this project has values for · hover a cell for its source)
Loading the sample table…